155 results
Page 5 of 8
8-K
EX-99.1
ytwh4d5jgm
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
d05qm
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
f5iwb2ai40dg1ifgdwe3
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.2
fjg507wrm 38fvmi5fc
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-1.1
f4uxmje
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.1
zmsyj91v
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
71tg1fwol2k7 6aj
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
i21zz0
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
84g6ilb2000xebezcu
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
EX-99.1
l5perd6 aermx4fczjy
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
EX-99.2
6zob2mfzqt 35x8njp
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
z3os3
18 Mar 20
Automatic shelf registration
10:00pm
8-K
EX-99.2
zfyov zo8rws5
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
ed0wnpv7rp8jh00
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
30wn j0hv
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm